ClinVar Miner

Submissions for variant NM_000212.3(ITGB3):c.760C>A (p.Gln254Lys)

dbSNP: rs2065102917
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen RCV001290469 SCV001478505 likely pathogenic Glanzmann thrombasthenia 2023-12-19 reviewed by expert panel curation The NM_000212.3(ITGB3):c.760C>A (p.Gln254Lys) missense variant is reported in at least 1 compound heterozygous GT proband as well as one additional affected family member (PMID: 31088191; PP1_supporting), with the likely pathogenic variant Cys549Ser (PM3). Proband 2 of PMID: 31088191 was a 6-year-old girl diagnosed with recurrent hematemesis at age 2. Platelet aggregation was absent or defective upon stimulation with physiological stimuli like AA and ADP, but platelets agglutinated near normal in response to ristocetin. Flow cytometric studies found reduced expression of αIIbβ3. Together this is highly specific for Glanzmann thrombasthenia (PP4_Moderate) It is absent from all population databases, including gnomAD (PM2_Supporting) and is predicted damaging by in-silico tools (REVEL score of 0.972; PP3). In summary, this variant meets criteria to be classified as Likely Pathogenic for GT. GT-specific criteria applied: PM2_Supporting, PM3, PP1, PP3, and PP4_Moderate.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.